Levamisole, IL-2, and granulocyte-macrophage colony-stimulating factor (GM-SF) are commonly employed as vaccine adjuvants in recombinant hepatitis B vaccines [164]. The gene discussed is CSF2; the disease is hepatitis B virus infection.